Clinical Study

High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study

Table 2

Significant predictors of eGFR at different time points of late posttransplant period.

Predictive variablesUnivariate linear regressionMultivariate linear regression
BetaSE valueBetaSE value

eGFR at baseline (mL/min/1.73 m2),
Log proteinuria/creatinine−0.4880.104<0.001−0.4060.1530.012
Impaired initial function−0.2350.1120.040
Log mean arterial pressure−0.5020.099<0.001−0.3320.1530.037
Previous acute rejection−0.2410.1120.035

eGFR after 1 year of follow-up (mL/min/1.73 m2),
eGFR at baseline 0.8700.057<0.0010.7210.091<0.001
Log proteinuria/creatinine−0.4760.105<0.001
Serum β2MG−0.5380.137<0.001−0.2910.0910.003
Impaired initial function−0.2330.1130.042
Log mean arterial pressure−0.4360.103<0.001
Time after transplantation−0.2620.1110.021

eGFR after 2 years of follow-up (mL/min/1.73 m2),
eGFR at baseline 0.8380.063<0.0010.6490.101<0.001
Log proteinuria/creatinine−0.4730.105<0.001
Serum β2MG−0.5270.138<0.001−0.3020.0980.004
Impaired initial function−0.2300.1130.030
Log mean arterial pressure−0.4470.103<0.001
Time after transplantation −0.3320.1080.003−0.1480.0970.135
Previous acute rejection−0.2610.1120.023

β2MG: β2-microglobulin; eGFR: estimated glomerular filtration rate; beta: standardized regression coefficient; SE: standard error of beta; : number of patients investigated; only variables that significantly influenced the eGFR in univariate analysis are included; natural log-transformed variables; impaired initial function and acute rejection scored in points.